Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
02:20:17 EST Sat 17 Jan 2026
Enter Symbol
or Name
USA
CA



Q:AVAI - AVANT TECHNOLOGIES INC - https://ir.avanttechnologies.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
AVAI - Qnot subscribed0.7401-0.03685-4.7210.11511450.79  0.80  0.700.84  0.219115:56:19Jan 1415 min RT 2¢

Recent Trades - Last 10 of 145
Time ETExPriceChangeVolume
15:56:19Q0.7401-0.03685300
15:55:29Q0.76-0.0169510,225
15:51:06Q0.76-0.01695990
15:45:01Q0.77-0.00695400
15:44:38Q0.77-0.0069510
15:44:10Q0.77-0.006954,775
15:29:39Q0.77-0.00695335
15:29:28Q0.75086-0.026091,000
15:29:28Q0.77-0.006951,000
15:29:28Q0.77-0.00695300

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-01-14 10:15U:AVAINews ReleaseTHE SOVEREIGN MANDATE: 5 Stocks Securing the 2026 Choke Points
2025-12-17 10:21U:AVAINews ReleaseTHE FOUNDATION TRADE: 5 Assets Anchoring the Next Industrial Cycle
2025-12-16 12:00U:AVAINews ReleaseFrom Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes
2025-12-16 11:53U:AVAINews ReleaseBeyond Insulin Pumps: Cell Therapies Unlock a $403B Cure Economy
2025-12-16 08:15U:AVAINews ReleaseAvant Technologies Highlights the Critical Role of Cell Encapsulation Technology in Revolutionizing Diabetes Treatment
2025-12-15 10:55U:AVAINews ReleaseTHE VISIBILITY INDEX: 5 Companies Solving the Invisible Crisis
2025-12-09 11:57U:AVAINews ReleaseBeyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions
2025-12-09 08:30U:AVAINews ReleaseAvant Technologies and Austrianova Advancing alpha-Klotho Cell Therapy as Mayo Clinic Study Links Low alpha-Klotho Levels to Poor Cardiovascular Survival
2025-12-08 09:12U:AVAINews ReleaseTHE CRITICAL LIST: 5 Stocks Anchoring the New Economy
2025-12-06 13:51U:AVAINews ReleaseTHE EFFICIENCY PARADOX: 5 Market Anomalies Trading Below Reality
2025-11-18 08:45U:AVAINews ReleaseLongevity-Focused Health Fueling U.S. Anti-Aging Products Market Projected to Reach $27 Billion By 2033
2025-11-18 08:00U:AVAINews ReleaseAvant Technologies and Austrianova Secure Exclusive License for Klotho Producing Cell Line to Advance Anti-Aging Therapies
2025-11-04 08:00U:AVAINews ReleaseAvant Technologies Signs Joint Venture to Advance Cell-Based Diabetes Treatment
2025-10-21 08:00U:AVAINews ReleaseAvant Technologies and Austrianova Launch Klothonova, Begin Developing Age Related Cellular Therapies Using 'Longevity Protein' Klotho